Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-03-22 @ 4:53 PM
Study NCT ID:
NCT00671112
Status:
TERMINATED
Last Update Posted:
2015-10-28
First Post:
2008-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor:
Brian Hill, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE2407
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None